Biotricity (OTCMKTS:BTCY) Issues Quarterly Earnings Results

Biotricity (OTCMKTS:BTCY) announced its earnings results on Wednesday. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.06, Zacks reports.

Biotricity Price Performance

Shares of BTCY traded up $0.06 during midday trading on Wednesday, reaching $0.66. The stock had a trading volume of 113,070 shares, compared to its average volume of 47,530. Biotricity has a 52 week low of $0.19 and a 52 week high of $1.67. The firm’s 50 day moving average price is $0.35 and its 200-day moving average price is $0.36. The company has a market capitalization of $16.21 million, a P/E ratio of -0.39 and a beta of 1.18.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.